South Korea · Delayed Price · Currency is KRW BIOBIJOU Statistics
Total Valuation
BIOBIJOU has a market cap or net worth of KRW 102.45 billion. The enterprise value is 75.43 billion.
| Market Cap | 102.45B |
| Enterprise Value | 75.43B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
BIOBIJOU has 15.04 million shares outstanding. The number of shares has increased by 25.60% in one year.
| Current Share Class | 15.04M |
| Shares Outstanding | 15.04M |
| Shares Change (YoY) | +25.60% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 17.34% |
| Owned by Institutions (%) | 5.84% |
| Float | 3.79M |
Valuation Ratios
The trailing PE ratio is 18.68.
| PE Ratio | 18.68 |
| Forward PE | n/a |
| PS Ratio | 4.11 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 1.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 21,848.72 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.71, with an EV/FCF ratio of -197.91.
| EV / Earnings | 14.09 |
| EV / Sales | 3.03 |
| EV / EBITDA | 13.71 |
| EV / EBIT | 15.96 |
| EV / FCF | -197.91 |
Financial Position
The company has a current ratio of 12.46, with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.46 |
| Quick Ratio | 9.90 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | -0.84 |
| Interest Coverage | 259.40 |
Financial Efficiency
Return on equity (ROE) is 11.35% and return on invested capital (ROIC) is 9.58%.
| Return on Equity (ROE) | 11.35% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.58% |
| Return on Capital Employed (ROCE) | 7.44% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BIOBIJOU has paid 1.25 billion in taxes.
| Income Tax | 1.25B |
| Effective Tax Rate | 18.93% |
Stock Price Statistics
The stock price has decreased by -65.27% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -65.27% |
| 50-Day Moving Average | 7,786.60 |
| 200-Day Moving Average | 12,151.05 |
| Relative Strength Index (RSI) | 43.53 |
| Average Volume (20 Days) | 85,077 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIOBIJOU had revenue of KRW 24.92 billion and earned 5.35 billion in profits. Earnings per share was 364.64.
| Revenue | 24.92B |
| Gross Profit | 15.81B |
| Operating Income | 4.73B |
| Pretax Income | 6.60B |
| Net Income | 5.35B |
| EBITDA | 5.50B |
| EBIT | 4.73B |
| Earnings Per Share (EPS) | 364.64 |
Balance Sheet
The company has 27.36 billion in cash and 318.89 million in debt, with a net cash position of 27.04 billion or 1,797.49 per share.
| Cash & Cash Equivalents | 27.36B |
| Total Debt | 318.89M |
| Net Cash | 27.04B |
| Net Cash Per Share | 1,797.49 |
| Equity (Book Value) | 63.36B |
| Book Value Per Share | 4,208.75 |
| Working Capital | 47.99B |
Cash Flow
In the last 12 months, operating cash flow was 4.69 million and capital expenditures -385.82 million, giving a free cash flow of -381.14 million.
| Operating Cash Flow | 4.69M |
| Capital Expenditures | -385.82M |
| Depreciation & Amortization | 773.68M |
| Net Borrowing | -351.75M |
| Free Cash Flow | -381.14M |
| FCF Per Share | -25.33 |
Margins
Gross margin is 63.44%, with operating and profit margins of 18.97% and 21.49%.
| Gross Margin | 63.44% |
| Operating Margin | 18.97% |
| Pretax Margin | 26.50% |
| Profit Margin | 21.49% |
| EBITDA Margin | 22.07% |
| EBIT Margin | 18.97% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.49%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 1.49% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -25.60% |
| Shareholder Yield | -24.11% |
| Earnings Yield | 5.23% |
| FCF Yield | -0.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIOBIJOU has an Altman Z-Score of 32.62 and a Piotroski F-Score of 3.
| Altman Z-Score | 32.62 |
| Piotroski F-Score | 3 |